95 related articles for article (PubMed ID: 10087242)
1. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women.
Skelton DA; Phillips SK; Bruce SA; Naylor CH; Woledge RC
Clin Sci (Lond); 1999 Apr; 96(4):357-64. PubMed ID: 10087242
[TBL] [Abstract][Full Text] [Related]
2. Follow-up study of the benefits of hormone replacement therapy on isometric muscle strength of adductor pollicis in postmenopausal women.
Onambele NG; Skelton DA; Bruce SA; Woledge RC
Clin Sci (Lond); 2001 Apr; 100(4):421-2. PubMed ID: 11256982
[No Abstract] [Full Text] [Related]
3. Oestrogen status in relation to the early training responses in human thumb adductor muscles.
Onambele GN; Bruce SA; Woledge RC
Acta Physiol (Oxf); 2006 Sep; 188(1):41-52. PubMed ID: 16911252
[TBL] [Abstract][Full Text] [Related]
4. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy.
Greeves JP; Cable NT; Reilly T; Kingsland C
Clin Sci (Lond); 1999 Jul; 97(1):79-84. PubMed ID: 10369797
[TBL] [Abstract][Full Text] [Related]
5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
6. Mechanical force spinal manipulation increases trunk muscle strength assessed by electromyography: a comparative clinical trial.
Keller TS; Colloca CJ
J Manipulative Physiol Ther; 2000; 23(9):585-95. PubMed ID: 11145798
[TBL] [Abstract][Full Text] [Related]
7. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
10. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy.
Song EK; Yeom JH; Shin HT; Kim SH; Shin WG; Oh JM
J Clin Pharm Ther; 2006 Oct; 31(5):421-7. PubMed ID: 16958819
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
Jacobsen DE; Samson MM; Kezic S; Verhaar HJ
Maturitas; 2007 Sep; 58(1):7-18. PubMed ID: 17576043
[TBL] [Abstract][Full Text] [Related]
13. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
[TBL] [Abstract][Full Text] [Related]
14. Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women.
Hansen RD; Raja C; Baber RJ; Lieberman D; Allen BJ
Acta Diabetol; 2003 Oct; 40 Suppl 1():S191-5. PubMed ID: 14618470
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density.
Woods D; Onambele G; Woledge R; Skelton D; Bruce S; Humphries SE; Montgomery H
J Clin Endocrinol Metab; 2001 May; 86(5):2200-4. PubMed ID: 11344227
[TBL] [Abstract][Full Text] [Related]
16. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
[TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
19. The effect of habitual physical activity, non-athletic exercise, muscle strength, and VO2max on bone mineral density is rather low in early postmenopausal osteopenic women.
Kemmler W; Weineck J; Kalender WA; Engelke K
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):325-34. PubMed ID: 15615501
[TBL] [Abstract][Full Text] [Related]
20. Effects of strength training on muscle strength, cross-sectional area, maximal electromyographic activity, and serum hormones in premenopausal women with fibromyalgia.
Häkkinen K; Pakarinen A; Hannonen P; Häkkinen A; Airaksinen O; Valkeinen H; Alen M
J Rheumatol; 2002 Jun; 29(6):1287-95. PubMed ID: 12064848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
